
#AI #datascience insights for patients, biopharma, agtech, hospitals and governments @SASSoftware | PhD Bioscience Eng. cell & gene #kuleuven | #badminton
Belgium
Joined March 2008
- Tweets4.5K
- Following1.4K
- Followers875
- Likes3.1K
Mark Lambrecht retweeted
I have to say, when Merck called me last night with the mRNA cancer vaccine news (embargoed, of course), I literally yelped in reaction.
Consider this: Between this spring's Revolution Medicines success with a KRAS-targeted drug and now Merck and Moderna's success with an mRNA neoantigen vaccine, 2026 will go down as one of the most consequential years in cancer treatment, ever.
Incredible.
SAS data scientist Jim Box discusses how Bayesian methodologies are now recognized as an appropriate and, in some cases, advantageous framework for modern clinical trials. 2.sas.com/6016B6yKoC
Covid raises risk of heart issues in children more than vaccination | New Scientist newscientist.com/article/250…
Roshan Shah, VP of Al at Georgia-Pacific and Bill Clifford, VP and General Manager for Unreal Engine at Epic Games, share how their companies have partnered with SAS to create simulations, resulting in more efficient, effective and safe workspaces.
#SASInnovate #DigitalTwins
⚡ Help Carnegie Science investigators explore life, our planet, and the universe! give.carnegiescience.edu/cam…
Reasons to be hopeful: five ways science is making the world better | World news theguardian.com/world/2024/n…
I can now be followed on Bluesky at @mlambrecht.bsky.social - I advise the @openvibe_social app to follow across Bluesky, Mastodon and Nostr
Analytics is crucial in the fight against cancer, enhancing care and diagnosis. The Centre Oscar Lambret is at the forefront, creating personalized care pathways for patients all while using SAS Viya. @SASsoftware 2.sas.com/6017Szzr5
Hurah!
We know you're loving the new album booklets feature.
Here's a particularly special example, including the libretto and archive images to bring the recording to life: apple.co/LaBoheme 📖
--
#Pavarotti #Freni #LaBoheme #Karajan #WorldOperaDay
We knew it to be true, but we love pointing to the proof! 👉 A Futurum Group analysis found SAS Viya helps users execute the life cycle of collecting data, building models, and deploying decisions 4.6x faster than selected competitors! 2.sas.com/6012qkDEr
Are Liquid Biopsies the Future of Cancer Biomarkers in Diagnosis or Monitoring of Disease? globalforum.diaglobal.org/is…
Mark Lambrecht retweeted
BREAKING NEWS
The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Physics to John J. Hopfield and Geoffrey E. Hinton “for foundational discoveries and inventions that enable machine learning with artificial neural networks.”
Mark Lambrecht retweeted
Replying to @NobelPrize
Their most renowned research:
"The paper discusses the current understanding of how microRNAs function in the nematode Caenorhabditis elegans (C. elegans). Researchers have used C. elegans as a model organism to study microRNA biology and gain insights that are applicable to other animals, including humans."
"The researchers found that microRNAs in C. elegans regulate diverse biological processes, including larval development, longevity, stress responses, and neuronal development. They also discovered mechanisms that control microRNA biogenesis, stability, and activity, such as the involvement of Argonaute proteins and regulators of miRNA-induced silencing complexes (miRISCs)."
full paper: openread.academy/en/paper/re…
Mark Lambrecht retweeted
BREAKING NEWS
The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
Ready to embrace GenAI? Susan Lenderts, Global Head of Life Sciences at SAS, shares three crucial considerations for life sciences organizations.
2.sas.com/6018Ub1IY
Dr. Greg Goldmacher from Merck weighs in on AI’s potential to enable diagnosis and opportunistic screening. #TheHealthPulse podcast.
2.sas.com/6015UZgOS
Synthetic data can fill gaps in life science data sets and help address patient privacy and ethical concerns. How is your company addressing the opportunity to utilize synthetic #data generation in your business? Watch to learn more. 2.sas.com/6012UnHFG
Pharma’s journey from molecule to market demands speed and precision. Modern data science is key to accelerating timelines and enhancing therapy quality.
Discover insights by Soundarya Palanisamy in September’s PharmaTimes.
Read the full article here: 2.sas.com/6019UJ3qc
AI and globalisation are shaking up software developers’ world economist.com/business/2024/…
Mark Lambrecht retweeted
An exciting advance in Type 1 diabetes
First person to receive her own stem cells, reprogrammed with transcription factors, to reverse it!
@CellCellPress
sciencedirect.com/science/ar…
@Nature
nature.com/articles/d41586-0…













